¼¼°èÀÇ Ç÷¾× ¹è¾ç °Ë»ç ½ÃÀå º¸°í¼­(2025³â)
Blood Culture Tests Global Market Report 2025
»óǰÄÚµå : 1641667
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,183,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 8,938,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,692,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Ç÷¾× ¹è¾ç °Ë»ç ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³âµ¿¾È ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 14.7%·Î 130¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº º´¿ø ³» °¨¿° Áõ°¡, ÇöÀåÁø´Ü(POC) °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ µî¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¿ø°Ý ÀÇ·á ¹× ¿ø°Ý °Ë»ç, ÀÚµ¿È­ ¹× AI, ´ÙÁß °Ë»ç, ÆÐÇ÷Áõ °ü¸®, °¨¿° °¨½Ã µîÀÌ ÀÖ½À´Ï´Ù.

°¨¿°¼º ÁúȯÀÇ ¹ßº´·ü Áõ°¡´Â Ç÷¾× ¹è¾ç °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °¨¿°¼º ÁúȯÀº ¹ÙÀÌ·¯½º, ¼¼±Õ, °õÆÎÀÌ, ±â»ýÃæ°ú °°Àº º´¿øÃ¼¿¡ ÀÇÇØ ¹ß»ýÇÕ´Ï´Ù. Äڷγª19, °áÇÙ, µ¶°¨, È«¿ª, HIV, ¿¬¼â»ó±¸±Õ °¨¿°°ú °°Àº Áúº´Àº ÀϽÃÀûÀÎ ºÒÆíÇÔ, ½É°¢ÇÑ Á¶Á÷ ¼Õ»ó ¶Ç´Â »ç¸ÁÀ» À¯¹ßÇÒ ¼ö ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ À¯ÇØÇÑ ¹Ì»ý¹°Àº ¿ÜºÎ·ÎºÎÅÍ ¶Ç´Â °¨¿°µÈ »ç¶÷°úÀÇ Á¢ÃËÀ» ÅëÇØ ÀÎü¿¡ ħÀÔÇÕ´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)´Â °¨¿°º´ÀÌ Àü ¼¼°è »ç¸Á ¿øÀÎ Áß 2À§¸¦ Â÷ÁöÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ·¯ÇÑ °¨¿° ȯÀÚ Áõ°¡·Î ÀÎÇØ »ý¸íÀ» À§ÇùÇÒ ¼ö ÀÖ´Â ±ÕÇ÷ÁõÀ̳ª ÆÐÇ÷Áõ °¨¿° ¿©ºÎ¸¦ ÆÇ´ÜÇϱâ À§ÇÑ Ç÷¾× ¹è¾ç °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 8¿ù ¿µ±¹ º¸°Ç¾ÈÀüûÀÇ º¸°í¿¡ µû¸£¸é, 2022³â 12¿ù 31ÀÏ ÇöÀç ¿µ±¹¿¡¼­´Â ÁÖ·Î À×±Û·£µå¿¡¼­ 3,732°ÇÀÇ ¿¥ÆÅ½º ȯÀÚ°¡ È®ÀεǾúÀ¸¸ç, 2023³â 5¿ù 31ÀϱîÁö À×±Û·£µå¸¦ Áß½ÉÀ¸·Î 21°ÇÀÌ Ãß°¡·Î º¸°íµÇ¾ú°í, ½ºÄÚÆ²·£µå¿¡¼­µµ 1°ÇÀÌ º¸°íµÇ¾ú½À´Ï´Ù. º¸°íµÇ¾ú½À´Ï´Ù. ÀÌ¿¡ µû¶ó, °¨¿°ÁõÀÇ ¹ßº´·ü Áõ°¡°¡ Ç÷¾× ¹è¾ç °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä¸¦ °ßÀÎÇϰí ÀÖ½À´Ï´Ù.

Ç×»ýÁ¦ ³»¼º±Õ Áõ°¡´Â ÇâÈÄ Ç÷¾×¹è¾ç°Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Ç×»ýÁ¦ ³»¼ºÀº ¹ÚÅ׸®¾Æ, ¹ÙÀÌ·¯½º, ±âŸ ¹Ì»ý¹°ÀÌ ÀÌÀü¿¡ Ç×»ýÁ¦³ª Ç×±ÕÁ¦ÀÇ È¿°ú¿¡ ÀúÇ×ÇÒ ¼ö ÀÖ´Â ´É·ÂÀ» ÀǹÌÇϸç, ÀÌ·¯ÇÑ ¹Ì»ý¹°·Î ÀÎÇÑ °¨¿°À» Ä¡·áÇÏ´Â µ¥ È¿°úÀûÀ̾ú½À´Ï´Ù. Ç×»ýÁ¦ ³»¼º °¨¿°ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó °¡Àå È¿°úÀûÀÎ Ä¡·á¹ýÀ» ã±â À§ÇØ Ç÷¾× ¹è¾ç °Ë»ç¸¦ Æ÷ÇÔÇÑ º¸´Ù Á¾ÇÕÀûÀÎ Áø´Ü °Ë»ç°¡ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹¿¡ º»ºÎ¸¦ µÐ Á¤ºÎ °£ ±â±¸ÀÎ ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ 2023³â 11¿ù º¸°í¼­¿¡ µû¸£¸é, Ç×»ýÁ¦ ³»¼º °¨¿°ÀÇ °æÁ¦Àû ¿µÇâÀº 2030³â 1Á¶ ´Þ·¯¿¡¼­ 2050³â 1Á¶ ´Þ·¯¿¡¼­ 3Á¶ 4,000¾ï ´Þ·¯·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌó·³ Ç×»ýÁ¦ ³»¼º Áõ°¡·Î ÀÎÇÑ ¼ö¿ä Áõ°¡°¡ Ç÷¾× ¹è¾ç °Ë»ç ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ÄڷγªÀç³­, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ½ÃÀåÀÇ ÃÖ±Ù µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Blood culture tests are diagnostic procedures designed to identify disease-causing microorganisms present in the bloodstream. These tests play a crucial role in detecting infections caused by various microorganisms such as bacteria, yeast, and other foreign invaders in a blood sample.

The primary methods employed in blood culture tests include conventional/manual methods and automated methods. The conventional or manual method is utilized to detect invaders like bacteria, yeast, and other microorganisms in a blood specimen. Manual testing involves the hands-on examination and interpretation of results by skilled testers. Blood culture products encompass consumables, instruments, and software and services that leverage technologies such as culture-based technology, molecular technologies, microarrays, PCR (polymerase chain reaction), PNA-FISH (peptide nucleic acid - fluorescent in situ hybridization), and proteomics technology. These technologies are applied in the detection of bacteremia, fungemia, and mycobacterial infections. Blood culture tests are commonly utilized by hospital laboratories, reference laboratories, academic research laboratories, and other testing facilities.

The blood culture tests market research report is one of a series of new reports from The Business Research Company that provides blood culture tests market statistics, including blood culture tests industry global market size, regional shares, competitors with a blood culture tests market share, detailed blood culture tests market segments, market trends and opportunities, and any further data you may need to thrive in the blood culture tests industry. This blood culture tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood culture tests market size has grown rapidly in recent years. It will grow from $6.79 billion in 2024 to $7.57 billion in 2025 at a compound annual growth rate (CAGR) of 11.4%. The growth in the historic period can be attributed to increase in prevalence of infectious diseases, aging population, advances in healthcare infrastructure, rise in research and development.

The blood culture tests market size is expected to see rapid growth in the next few years. It will grow to $13.09 billion in 2029 at a compound annual growth rate (CAGR) of 14.7%. The growth in the forecast period can be attributed to rising hospital-acquired infections, growing demand for point-of-care (poc) testing, increased healthcare spending, regulatory approvals. Major trends in the forecast period include telemedicine and remote testing, automation and ai, multiplex testing, sepsis management, infectious disease surveillance.

The rising incidence of infectious diseases is expected to drive the growth of the blood culture test market. Infectious diseases are caused by pathogens such as viruses, bacteria, fungi, and parasites. These harmful microorganisms can enter the body from external sources or through contact with an infected individual. Diseases like COVID-19, tuberculosis, the flu, measles, HIV, and strep throat can cause temporary discomfort, severe tissue damage, or even death. The World Health Organization identifies infectious diseases as the second leading cause of death globally. This increase in infectious disease cases has fueled the demand for blood culture tests, which help determine whether a patient has bacteremia or septicemia, potentially life-threatening conditions. For example, in August 2024, according to a report by the UK Health Security Agency, as of December 31, 2022, there were 3,732 confirmed mpox cases in the UK, primarily in England. By May 31, 2023, 21 additional cases were reported, mainly in England, with one in Scotland. As a result, the growing incidence of infectious diseases is driving demand for blood culture tests.

The rise in antibiotic resistance is expected to drive the growth of the blood culture test market in the future. Antibiotic resistance refers to the ability of bacteria, viruses, or other microorganisms to resist the effects of antibiotics or antimicrobial drugs that were previously effective in treating infections caused by these organisms. The increase in antibiotic-resistant infections requires more comprehensive diagnostic testing, including blood culture tests, to identify the most effective treatment options. For example, in November 2023, according to a report from the World Health Organization, a US-based intergovernmental organization, antibiotic-resistant infections are projected to increase from $1 trillion in 2030 to between $1 trillion and $3.4 trillion by 2050. Thus, the rising demand due to increasing antibiotic resistance is contributing to the growth of the blood culture test market.

Technological innovation emerges as a prominent trend influencing the blood culture test market. In the dynamic landscape of pharmaceuticals, biologics, nutraceuticals, and medical devices, innovation is key to meeting evolving industry requirements. The imperative to bring new products to market efficiently and cost-effectively has led manufacturers to develop cutting-edge blood culture testing technologies. Notably, Labcorp introduced the Labcorp OnDemandTM at-home collection kit in May 2022. This innovative kit utilizes dried blood technology to measure hemoglobin A1c from a small blood sample, providing users with insights into their average blood sugar levels over time. Technological advancements like this not only enhance accuracy and safety but also enable individuals to monitor their health conveniently from the comfort of their homes, fostering the growth of the blood culture test market.

Major companies in the organic blood culture tests market are focusing on developing advanced technologies, such as clinical chemistry technologies, to improve diagnostic accuracy, decrease turnaround times, and enhance patient management through integrated testing solutions that deliver comprehensive insights into infections and related health issues. Clinical chemistry technologies refer to diagnostic methods and instruments utilized to analyze bodily fluids, primarily blood, to measure chemical components and evaluate health conditions. For example, in April 2024, Mindray Medical International Limited, a medical device company based in China, launched mid-volume laboratories. These innovations demonstrate Mindray's dedication to supporting mid-volume laboratories by offering simple yet effective solutions that boost diagnostic capabilities while meeting the growing demands of healthcare providers.

In April 2022, BioMerieux India Pvt Ltd, a provider of in vitro diagnostic solutions based in India, acquired Specific Diagnostics for an undisclosed amount. This acquisition aims to improve public health by delivering innovative in vitro diagnostic solutions. Specific Diagnostics is an India-based company that produces the SPECIFIC REVEAL Rapid AST system for testing.

Major companies operating in the blood culture tests market include Becton, Dickinson and Company, BioMerieux SA, Thermo Fisher Scientific Inc., Luminex Corporation, Danaher Corporation, Terumo Corporation, Bruker Corporation, F. Hoffmann-La Roche AG, Biobase Biotech Co. Ltd., Scenker Biological Technology Co. Ltd., Bulldog Bio, Anaerobe Systems Inc., Himedia Laboratories Pvt. Ltd., Autobio Diagnostics Co. Ltd., Axiom Laboratories, Biosystems Inc., BINDER GmBH, Roche Diagnostics, Mikroscan Technologies Inc., Labotronics Ltd., Hardy Diagnostics, OpGen Inc., Meditech Technologies India Private Limited, Siemens Healthineers, Abbott Laboratories, Cepheid, T2 Biosystems Inc., Beckman Coulter Inc., Accelerate Diagnostics, Bio-Rad Laboratories Inc., Hologic Inc., Quidel Corporation, Copan Diagnostics Inc., Greiner Bio-One International GmbH, Carl Zeiss AG, Nanosphere Health Sciences, GenMark Diagnostics, Meridian Bioscience Inc., Nikon Corporation

North America was the largest region in the blood culture tests market in 2024. The regions covered in the blood culture tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the blood culture tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and USA.

The blood culture tests include revenues earned by entities by micro sampling technology and blood chemistry analyzer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Culture Tests Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood culture tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for blood culture tests ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The blood culture tests market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Blood Culture Tests Market Characteristics

3. Blood Culture Tests Market Trends And Strategies

4. Blood Culture Tests Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Blood Culture Tests Growth Analysis And Strategic Analysis Framework

6. Blood Culture Tests Market Segmentation

7. Blood Culture Tests Market Regional And Country Analysis

8. Asia-Pacific Blood Culture Tests Market

9. China Blood Culture Tests Market

10. India Blood Culture Tests Market

11. Japan Blood Culture Tests Market

12. Australia Blood Culture Tests Market

13. Indonesia Blood Culture Tests Market

14. South Korea Blood Culture Tests Market

15. Western Europe Blood Culture Tests Market

16. UK Blood Culture Tests Market

17. Germany Blood Culture Tests Market

18. France Blood Culture Tests Market

19. Italy Blood Culture Tests Market

20. Spain Blood Culture Tests Market

21. Eastern Europe Blood Culture Tests Market

22. Russia Blood Culture Tests Market

23. North America Blood Culture Tests Market

24. USA Blood Culture Tests Market

25. Canada Blood Culture Tests Market

26. South America Blood Culture Tests Market

27. Brazil Blood Culture Tests Market

28. Middle East Blood Culture Tests Market

29. Africa Blood Culture Tests Market

30. Blood Culture Tests Market Competitive Landscape And Company Profiles

31. Blood Culture Tests Market Other Major And Innovative Companies

32. Global Blood Culture Tests Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Culture Tests Market

34. Recent Developments In The Blood Culture Tests Market

35. Blood Culture Tests Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â